News for Healthier Living

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Value in Health, the official journal of ISPOR--The Professional Society for Health Economics and Outcomes Research, announced today the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.

September 3, 2025


September 12 2025

September 11 2025

September 10 2025

September 9 2025

September 8 2025

September 7 2025

September 6 2025

September 5 2025

September 4 2025

September 3 2025

September 2 2025

September 1 2025

August 31 2025

August 30 2025